Search for a command to run...
Ticker: CPHL • | Sector: PHARMACEUTICALS
RevRevenue
✓ GoodRs. 13.15 B
ProfitNet Profit
~ AverageRs. 892.0 M
EPSEPS
✓ Good₨3.90
ROEROE
~ Average8.2%
P/EP/E
✗ Bad16.9x
YieldDividend Yield
✓ Good4.5%
Citi Pharma Ltd. has shown positive revenue growth of 6.0% over the past year. Net income has grown by 7.1% year-over-year. The company maintains a return on equity of 8.2%.
Company profile
CPHL • PHARMACEUTICALS
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
CPHL stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.